Makers Laboratories

Makers Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Makers Laboratories (506919.BO) as of Oct 18, 2026 is 7.79. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -10.40 — a change of -174.88% (higher).

EV/FCF

7.79

YoY

-174.88%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Makers Laboratories is 2026 7.79 . EV/FCF (Enterprise Value to Free Cash Flow) of Makers Laboratories was 2025 -10.40 . It decreases by -174.88% higher compared to the previous year.

The Makers Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
-42.97 INR
Jan 1, 2019
-24.08 INR
Jan 1, 2020
-20.87 INR
Jan 1, 2022
-64.40 INR
Jan 1, 2023
-4.09 INR
Jan 1, 2024
-15.64 INR
Jan 1, 2025
-10.40 INR
Jan 1, 2026
7.79 INR
The Makers Laboratories EV/FCF history
YEAREV/FCFYoY
7.79-174.88%
-10.40-33.50%
-15.64+282.23%
-4.09-93.65%
-64.40+208.59%
-20.87-13.34%
-24.08-43.95%
-42.97+82.74%
-23.51-143.09%
54.57-146.27%
-117.94+90.65%
-61.86—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India, operating within the Health Care sector. The company has a workforce of 121 employees and went public on July 13, 1993. It manufactures and markets pharmaceutical products, focusing on various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). Additionally, Makers Laboratories offers Inspira retail packs, covering categories like acid regulatory, anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics, anti-nauseants, anti-fungal, anti-hypertensives, and other health-related products. The Experia bulk packs division provides bulk pharmaceutical products including amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and similar items. The company's website is https://www.makerslabs.com/. Makers Laboratories Ltd is listed on the Bombay Stock Exchange under the ticker 506919.BO and holds the ISIN INE987A01010. The company operates through the pharmaceuticals segment, emphasizing general health therapeutic areas. It does not disclose specific financial figures or additional details beyond its product lines and operational structure. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of Makers Laboratories is 7.79 in 2026.

EV/FCF (Enterprise Value to Free Cash Flow) of Makers Laboratories changed from -10.40 to 7.79, representing a -174.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Makers Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Makers Laboratories

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Makers Laboratories